The digestive system plays an essential role in human health by managing nutrient intake, energy absorption, and waste excretion. Disorders within this system can lead to malnutrition and energy imbalance, which in turn may further trigger systemic health issues such as weakened immunity, delayed growth and development, metabolic disturbances, and even life-threatening conditions. The aetiology of many digestive diseases remains incompletely understood. For example, the formation of gastric ulcers is associated with factors such as excessive stomach acid, Helicobacter pylori infection, individual differences, genetic backgrounds, and environmental factors. Similarly, the pathogenesis of inflammatory bowel diseases involves complex interactions across multiple levels, including immune dysregulation, gut microbiota imbalance, and genetic susceptibility. However, the precise nature of the relationships and interaction mechanisms among these factors has not been fully elucidated. Owing to the diversity and complexity of digestive diseases, existing treatment methods often fail to achieve radical cures. Furthermore, with the accelerating aging of the population, the incidence of digestive system cancers, such as gastric cancer, liver cancer, and colorectal cancer, continues to rise annually. Therefore, research into early diagnosis, precision treatment, and prognosis management for these cancers is more urgent than ever.
This Research Topic aims to gather the latest advancements in the aetiology and treatment of digestive system diseases. We are particularly interested in studies on the proliferation, senescence, death, and regeneration of digestive system cells. Additionally, we are keen to investigate the roles of genetic susceptibility, microbial imbalance, immune dysregulation, and environmental factors in the pathogenesis of these diseases. Furthermore, we aim to explore the therapeutic effects of drugs on digestive diseases through bioinformatics analyses and experimental approaches. Our objective is to uncover the underlying mechanisms of digestive diseases, thereby providing novel insights and strategies for their treatment and drug development. Ultimately, our goal is to contribute to human health by achieving favourable therapeutic outcomes for digestive system diseases.
Our priorities encompass the pathogenesis and treatment of digestive diseases. We will give precedence to research into the pathogenic mechanisms involving microorganisms, genetic factors, environmental factors, and their interactions. Additionally, we are focused on the therapeutic effects and mechanisms of related medications, as well as the investigation of alternative treatment approaches. We welcome submissions focusing on the following sub-themes, among others:
• Proliferation, senescence, death, and regeneration of digestive system cells.
• The role of microorganisms in the pathogenesis of digestive diseases and new methods for detecting gastrointestinal microbiota.
• The relationship between digestive system diseases and genetic susceptibility.
• Immune dysregulation and its association with digestive system diseases.
• Environmental factors influencing digestive system diseases.
• Drug discovery, pharmacological research, and targeted drug therapy related to digestive system diseases.
The digestive system plays an essential role in human health by managing nutrient intake, energy absorption, and waste excretion. Disorders within this system can lead to malnutrition and energy imbalance, which in turn may further trigger systemic health issues such as weakened immunity, delayed growth and development, metabolic disturbances, and even life-threatening conditions. The aetiology of many digestive diseases remains incompletely understood. For example, the formation of gastric ulcers is associated with factors such as excessive stomach acid, Helicobacter pylori infection, individual differences, genetic backgrounds, and environmental factors. Similarly, the pathogenesis of inflammatory bowel diseases involves complex interactions across multiple levels, including immune dysregulation, gut microbiota imbalance, and genetic susceptibility. However, the precise nature of the relationships and interaction mechanisms among these factors has not been fully elucidated. Owing to the diversity and complexity of digestive diseases, existing treatment methods often fail to achieve radical cures. Furthermore, with the accelerating aging of the population, the incidence of digestive system cancers, such as gastric cancer, liver cancer, and colorectal cancer, continues to rise annually. Therefore, research into early diagnosis, precision treatment, and prognosis management for these cancers is more urgent than ever.
This Research Topic aims to gather the latest advancements in the aetiology and treatment of digestive system diseases. We are particularly interested in studies on the proliferation, senescence, death, and regeneration of digestive system cells. Additionally, we are keen to investigate the roles of genetic susceptibility, microbial imbalance, immune dysregulation, and environmental factors in the pathogenesis of these diseases. Furthermore, we aim to explore the therapeutic effects of drugs on digestive diseases through bioinformatics analyses and experimental approaches. Our objective is to uncover the underlying mechanisms of digestive diseases, thereby providing novel insights and strategies for their treatment and drug development. Ultimately, our goal is to contribute to human health by achieving favourable therapeutic outcomes for digestive system diseases.
Our priorities encompass the pathogenesis and treatment of digestive diseases. We will give precedence to research into the pathogenic mechanisms involving microorganisms, genetic factors, environmental factors, and their interactions. Additionally, we are focused on the therapeutic effects and mechanisms of related medications, as well as the investigation of alternative treatment approaches. We welcome submissions focusing on the following sub-themes, among others:
• Proliferation, senescence, death, and regeneration of digestive system cells.
• The role of microorganisms in the pathogenesis of digestive diseases and new methods for detecting gastrointestinal microbiota.
• The relationship between digestive system diseases and genetic susceptibility.
• Immune dysregulation and its association with digestive system diseases.
• Environmental factors influencing digestive system diseases.
• Drug discovery, pharmacological research, and targeted drug therapy related to digestive system diseases.